References

The Big Asthma Lie

Natural Treatment to get rid of Asthma

Get Instant Access

1. Phase 1 Clinical Trials. FDA Handbook. Accessed at http://www. fda.gov/cder/handbook/phase1.htm on February 12, 2005

2. Phase 2 Clinical Trials. FDA Handbook. Accessed at http://www. fda.gov/cder/handbook/phase2.htm on February 12, 2005

3. Phase 3 Clinical Trials. FDA Handbook. Accessed at http://www. fda.gov/cder/handbook/phase3.htm on February 12, 2005

4. E6 Good Clinical Practice: Consolidated Guidance. ICH. April 1996. Accessed at http://www.fda.gov/cder/guidance/959fnl.pdf on February 12, 2005

5. E10 Choice of Control Groups and Related Issues in Clinical Trials. ICH. May 2001. Accessed at http://www.fda.gov/cder/ guidance/ 4155fnl.pdf on February 12, 2005

6. Temple RJ. Active control non-inferiority studies: theory, assay sensitivity, choice of margin. February 10, 2002. Accessed at http://www.fda.gov/ohrms/dockets/ac/02/slides/3837s1_02_Tem ple/sld001.htm on February 12, 2005

7. Center for Drug Evaluation and Research. Procedures for tracking and reviewing phase 4 commitment. Accessed at http://www. fda.gov/c der/mapp/6010-2.pdf on February 12, 2005

8. Cramer JA, Spilker B. Quality of Life and Pharmacoeconomics: An Introduction. Philadelphia: Lippincott-Raven. 1997

9. Balekdjian D, Russo M. Managed care mandate: show us the value. Pharmaceutical Executive 2003;23 (Special report)

10. Adapted from Venturini F, Johnson K. Introduction to Pharmacoeconomic Principles and Application in Pharmacy Practice. Can J Hosp Pharm 2002;55(2):

11. Louie SG. How to conduct a pharmacoeconomics study. Educational monograph. USC School of Pharmacy. 2002

12. ACCP - Pharmacoeconomics and Outcomes, Applications for Patient Care (Educational program, Module 1, 2, 3) American College of Clinical Pharmacy Kansas City, MO

13. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30:473-483

14. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25-31

15. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579

16. Juniper EF, Guyatt GH, Epstein RS, Feme PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83

17. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996;5:35-46

18. The value of providing quality-of-life information to managed care decision makers. Drug Benefit Trends 2001; 13(7): 45-52

19. Shah J. Economic and regulatory considerations in pharmacoge-nomics for drug licensing and healthcare. Nature Biotechnology 2003;21(7):747-753

20. Bernard S. The 5 myths of pharmacogenomics. Pharmaceutical Executive 2003;23(10):70-78

21. Weinshilboum R, Wang L. Pharmacogenomics: bench to bedside. Nature Reviews Drug Discovery 2004;3(9):739-748

22. Lesko LJ, Woodcock J. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nature Reviews Drug Discovery 2004;3(9):763-769

23. Center for Drug Evaluation and Research. Pharmacogenomic data submission. November 2003. Accessed at http://www.fda. gov/cder/guidance/5900dft.doc on February 12, 2005

24. Faich G, Stemhagen A. Epidemiology and drug developmentā€”a primer. DIA Forum 2004;40(3):32-34

25. Etminan M, Samii A. Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs. Pharmacotherapy 2004;24(8):964-969

26. Food and Drug Administration. Challenge and opportunity on the critical path to new medical products. Accessed at http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html on February 12, 2005

Was this article helpful?

0 0
Dealing With Asthma Naturally

Dealing With Asthma Naturally

Do You Suffer From ASTHMA Chronic asthma is a paralyzing, suffocating and socially isolating condition that can cause anxiety that can trigger even more attacks. Before you know it you are caught in a vicious cycle Put an end to the dependence on inhalers, buying expensive prescription drugs and avoidance of allergenic situations and animals. Get control of your life again and Deal With Asthma Naturally

Get My Free Ebook


Post a comment